Royal Bank Of Canada Tenaya Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,721 shares of TNYA stock, worth $18,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,721

Previous 5,188 48.82%

Holding current value

$18,375

Previous $16,000 12.5%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.93 - $3.99 $4,888 - $10,106	2,533 Added 48.82%	7,721 $14,000
Q2 2024 Aug 14, 2024	BUY	$2.72 - $4.99 $11,222 - $20,588	4,126 Added 388.51%	5,188 $16,000
Q1 2024 Nov 05, 2024	SELL	$2.88 - $6.8 $11,882 - $28,056	-4,126 Reduced 79.53%	1,062 $5,000
Q1 2024 May 15, 2024	SELL	$2.88 - $6.8 $42,762 - $100,966	-14,848 Reduced 93.32%	1,062 $5,000
Q4 2023 Feb 14, 2024	BUY	$1.73 - $3.39 $13,789 - $27,021	7,971 Added 100.4%	15,910 $51,000
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.65 $8,065 - $17,870	3,163 Added 66.23%	7,939 $20,000
Q2 2023 Aug 14, 2023	BUY	$2.64 - $7.64 $6,188 - $17,908	2,344 Added 96.38%	4,776 $28,000
Q1 2023 May 15, 2023	SELL	$1.92 - $3.59 $5,070 - $9,481	-2,641 Reduced 52.06%	2,432 $6,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.19 $7,949 - $15,095	4,732 Added 1387.68%	5,073 $10,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $533 - $1,081	184 Added 117.2%	341 $1,000
Q2 2022 Aug 15, 2022	SELL	$5.01 - $14.12 $8,021 - $22,606	-1,601 Reduced 91.07%	157 $1,000
Q1 2022 May 16, 2022	SELL	$9.41 - $19.3 $10,774 - $22,098	-1,145 Reduced 39.44%	1,758 $21,000
Q4 2021 Feb 14, 2022	BUY	$18.41 - $29.58 $22,331 - $35,880	1,213 Added 71.78%	2,903 $55,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $26.66 $25,941 - $45,055	1,690 New	1,690 $35,000

Others Institutions Holding TNYA

# of Institutions

Shares Held

56.3M

Call Options Held

900

Put Options Held

400

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $98.4M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Tenaya Therapeutics, Inc. Transaction History